COLL PEER ANALYSIS

Collegium Pharmaceutical Inc — metric-by-metric comparison with peers and the industry median

COLLCollegium Pharmaceutical Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

COLLIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	COLL	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
P/E	19.48●	—	—	46.82	22.12	31.38	21.55
P/B	4.67	-0.89●	0.77	3.47	4.33	1.98	1.91
EV/EBITDA	3.03●	4.05	32.83	14.07	14.66	19.20	12.18
P/S	1.83	0.21●	4.88	1.86	3.93	3.95	2.13

Financial Health
Metric	COLL	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Current Ratio	1.71	1.32	1.73	1.33	3.66●	0.92	2.22
Debt/Equity	258.6%	-1,010.0%●	5.9%	41.0%	17.0%	52.3%	46.3%
NetDebt/EBITDA	0.63	3.71	-0.10●	1.10	0.09	3.50	1.24

Profitability
Metric	COLL	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Net Margin	9.4%	-13.5%	-3.6%	4.0%	17.8%●	12.6%	4.0%
ROE	27.4%●	—	-0.6%	8.7%	20.9%	6.3%	6.4%
ROA	4.6%	-4.7%	-0.5%	4.8%	15.1%●	3.2%	3.4%
EBITDA Margin	76.6%●	60.0%	14.8%	14.3%	27.0%	25.2%	18.2%

Growth + Dividend
Metric	COLL	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Rev. Growth	19.9%●	-9.9%	-2.3%	16.3%	-3.4%	-26.7%	7.5%
NI Growth	70.7%	—	—	146.6%●	-5.9%	-14.2%	5.0%
Div. Yield	—	0.0%	2.7%●	0.0%	1.6%	2.0%	2.0%
Payout	—	0.0%	-365.1%	0.0%	36.3%	40.0%	0.8%

Valuation
Metric	COLL	XERS	PRGO	HROW	PAHC	ANIP	Ind. Median
P/E	19.48	132.25	—	—	14.27●	20.66	21.55
P/B	4.67	122.05	0.62●	59.86	3.76	3.29	1.91
EV/EBITDA	3.03●	32.81	—	61.15	9.18	7.96	12.18
P/S	1.83	5.04	0.37●	6.40	0.91	2.01	2.13

Financial Health
Metric	COLL	XERS	PRGO	HROW	PAHC	ANIP	Ind. Median
Current Ratio	1.71	2.12	2.72	2.48	3.17●	3.12	2.22
Debt/Equity	258.6%	286.9%	152.3%	1,047.4%	217.6%	58.3%●	46.3%
NetDebt/EBITDA	0.63	-1.61	-2.78●	6.55	3.15	0.07	1.24

Profitability
Metric	COLL	XERS	PRGO	HROW	PAHC	ANIP	Ind. Median
Net Margin	9.4%	3.8%	-43.5%	-5.6%	6.3%	9.7%●	4.0%
ROE	27.4%	—	-53.0%	-35.1%	30.3%●	17.8%	6.4%
ROA	4.6%	3.4%	-20.5%	-3.8%	6.9%●	6.6%	3.4%
EBITDA Margin	76.6%●	14.7%	-29.7%	11.7%	15.0%	25.4%	18.2%

Growth + Dividend
Metric	COLL	XERS	PRGO	HROW	PAHC	ANIP	Ind. Median
Rev. Growth	19.9%	41.5%●	-3.6%	26.2%	26.0%	37.0%	7.5%
NI Growth	70.7%	—	—	—	199.6%●	—	5.0%
Div. Yield	—	—	11.3%●	—	1.5%	0.0%	2.0%
Payout	—	—	-8.7%	—	20.4%	0.8%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on COLL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.